The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation.

The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation.

Bibliographic Details
Main Authors: J Picot, K Cooper, J Bryant, AJ Clegg
Format: Article
Language:English
Published: NIHR Journals Library 2011-12-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta15410

Internet

https://doi.org/10.3310/hta15410

Similar Items